Vivian W Tsai, MD
Cardiovascular Disease (Cardiology) · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 11
Offices
11 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tsai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A88245 · Current
Licensed to practise in California · since 2004 · expires 2028-07-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$240,395
Medicare paid this office $240,395 for 1,149 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 282 | $54,691 | $193 |
| Long return visit (40+ min) | 184 | $53,753 | $156 |
| Return visit (30+ min) | 244 | $47,187 | $108 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 87 | $20,484 | $233 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $9,638 | $459 |
See all 25 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 282 | $54,691 | $193 |
| Long return visit (40+ min) | 184 | $53,753 | $156 |
| Return visit (30+ min) | 244 | $47,187 | $108 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 87 | $20,484 | $233 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $9,638 | $459 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,010 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 405 | $5,178 | $12 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 225 | $4,910 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,497 | $145 |
| Heart muscle strain imaging | 96 | $3,705 | $38 |
| Transitional care management services for problem of high complexity | 14 | $3,560 | $254 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 141 | $3,162 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $3,157 | $60 |
| New patient visit (60+ min) | 14 | $2,365 | $169 |
| Heart rhythm recording of continous external ekg over 8-15 days | 135 | $1,676 | $12 |
| Injection, perflutren lipid microspheres, per ml | 36 | $1,514 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 23 | $1,457 | $63 |
| Ultrasound of heart, follow-up | 13 | $1,358 | $97 |
| 3d radiographic procedure | 43 | $1,102 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 29 | $763 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $739 | $25 |
| Injection of x-ray contrast during ultrasound of heart | 18 | $657 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $460 | $24 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | $349 | $9 |
| Injection, regadenoson, 0.1 mg | 17 | $285 | None |
Who their Medicare patients are
1,149 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 19% · Women 55% · Also on Medicaid 19% · Health risk score 1.20. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 44% · Diabetes 35% · Chronic kidney disease 28% · Atrial fibrillation 28% · Heart failure 20% · Depression 15% · Cancer 14% · COPD 10% · Dementia 7% · Stroke 7%.
The office billed $1,080,777, Medicare allowed $322,155 and paid $240,395; for 2,912 services of 46 kinds; $2,501 of it was for drugs given in the office and $237,894 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,149 | 2,912 | 77 | 1.20 | $1,080,777 | $240,395 |
| 2023 | 1,090 | 2,812 | 77 | 1.18 | $1,057,806 | $250,171 |
| 2022 | 1,096 | 2,569 | 77 | 1.08 | $931,132 | $237,761 |
| 2021 | 1,182 | 3,014 | 76 | 1.22 | $1,077,652 | $277,894 |
| 2020 | 1,030 | 2,715 | 76 | 1.29 | $911,236 | $232,171 |
| 2019 | 1,302 | 3,408 | 76 | 1.41 | $1,206,012 | $296,003 |
| 2018 | 1,259 | 3,254 | 76 | 1.46 | $1,120,488 | $273,466 |
| 2017 | 1,342 | 3,010 | 76 | 1.32 | $1,006,668 | $265,369 |
| 2016 | 1,370 | 3,550 | 76 | 1.26 | $1,083,495 | $280,292 |
| 2015 | 1,405 | 4,643 | 76 | 1.29 | $1,028,252 | $283,768 |
| 2014 | 1,297 | 3,777 | 76 | 1.20 | $915,073 | $249,026 |
| 2013 | 1,068 | 2,099 | 75 | 1.25 | $677,186 | $166,292 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Long return visit (40+ min) | 188 | $56,994 | $158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $54,560 | $189 |
| Return visit (30+ min) | 251 | $49,107 | $108 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 55 | $12,679 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $12,348 | $106 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $11,213 | $467 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 400 | $5,170 | $12 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 29 | $5,146 | $177 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,860 | $154 |
| Heart muscle strain imaging | 92 | $3,671 | $39 |
| Injection, regadenoson, 0.1 mg | 17 | $2,877 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,748 | $61 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 109 | $2,645 | $23 |
| Injection, perflutren lipid microspheres, per ml | 36 | $2,218 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,694 | $63 |
| Heart rhythm recording of continous external ekg over 8-15 days | 110 | $1,468 | $13 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 22 | $1,437 | $33 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 15 | $1,137 | $76 |
| 3d radiographic procedure | 43 | $1,116 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $703 | $25 |
| Administration of influenza virus vaccine | 15 | $557 | $37 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $319 | $25 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $77 | None |
2022: 23 services
| Long return visit (40+ min) | 227 | $71,720 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 233 | $43,598 | $184 |
| Return visit (30+ min) | 234 | $42,379 | $105 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 13 | $8,642 | $332 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $8,152 | $480 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $7,499 | $234 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 34 | $6,460 | $190 |
| Heart muscle strain imaging | 147 | $5,907 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 440 | $5,529 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $5,445 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,782 | $158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 44 | $2,879 | $63 |
| Injection, regadenoson, 0.1 mg | 14 | $2,718 | None |
| New patient visit (60+ min) | 12 | $2,291 | $191 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 91 | $2,169 | $24 |
| 3d radiographic procedure | 77 | $1,830 | $23 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 24 | $1,686 | $70 |
| Injection, perflutren lipid microspheres, per ml | 21 | $1,414 | $36 |
| Heart rhythm recording of continous external ekg over 8-15 days | 89 | $1,308 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,252 | $63 |
| Administration of influenza virus vaccine | 24 | $880 | $37 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $681 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $311 | $26 |
2021: 28 services
| Long return visit (40+ min) | 214 | $65,563 | $158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 276 | $54,537 | $197 |
| Return visit (30+ min) | 245 | $47,115 | $104 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $14,704 | $507 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $10,779 | $234 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 47 | $9,050 | $193 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 29 | $8,639 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $6,723 | $90 |
| Heart muscle strain imaging | 154 | $6,499 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 430 | $5,945 | $13 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,121 | $177 |
| New patient visit (60+ min) | 24 | $4,424 | $184 |
| Injection, regadenoson, 0.1 mg | 23 | $4,381 | None |
| Transitional care management services for problem of at least moderate complexity | 17 | $3,980 | $199 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $3,510 | $63 |
| 3d radiographic procedure with computerized image postprocessing | 36 | $2,554 | $71 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 91 | $2,254 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $2,126 | $63 |
| 3d radiographic procedure | 68 | $1,571 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,384 | $77 |
| Heart rhythm recording of continous external ekg over 8-15 days | 86 | $1,378 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 47 | $1,187 | $21 |
| Ultrasound of heart, follow-up | 11 | $1,164 | $106 |
| Influenza vaccine split virus, preservative free | 17 | $1,109 | $65 |
| Injection, perflutren lipid microspheres, per ml | 13 | $803 | $37 |
| Blood test, clotting time | 69 | $794 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $563 | $27 |
| Administration of influenza virus vaccine | 16 | $337 | $21 |
2020: 31 services
| Long return visit (40+ min) | 193 | $49,393 | $133 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 228 | $46,305 | $199 |
| Return visit (30+ min) | 230 | $33,275 | $90 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 70 | $16,011 | $229 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $12,112 | $505 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,316 | $100 |
| 3d radiographic procedure with computerized image postprocessing | 85 | $6,131 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 337 | $5,217 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,990 | $192 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $4,724 | $98 |
| Telephone medical discussion with physician, 21-30 minutes | 39 | $4,292 | $107 |
| Injection, regadenoson, 0.1 mg | 22 | $4,131 | None |
| New patient visit (60+ min) | 20 | $3,858 | $193 |
| Heart muscle strain imaging | 84 | $3,574 | $42 |
| Transitional care management services for problem of at least moderate complexity | 12 | $2,394 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $2,359 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $1,980 | $64 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $1,472 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,430 | $79 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 58 | $1,370 | $23 |
| Influenza vaccine split virus, preservative free | 22 | $1,261 | $57 |
| Blood test, clotting time | 95 | $1,230 | $4 |
| External ekg recording for more than 48 hours up to 21 days | 47 | $1,217 | $25 |
| Ultrasound of heart, follow-up | 12 | $1,187 | $99 |
| Short return visit (20+ min) | 14 | $915 | $61 |
| Injection, perflutren lipid microspheres, per ml | 12 | $763 | $38 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $743 | $68 |
| 3d radiographic procedure | 22 | $507 | $23 |
| Administration of influenza virus vaccine | 23 | $472 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $432 | $27 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $333 | $28 |
2019: 28 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 297 | $61,867 | $205 |
| Long return visit (40+ min) | 248 | $61,617 | $126 |
| Return visit (30+ min) | 224 | $35,209 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $24,042 | $501 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 100 | $23,003 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $9,840 | $94 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $9,332 | $97 |
| Critical care, first 30-74 minutes | 12 | $8,668 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 504 | $8,249 | $15 |
| Injection, regadenoson, 0.1 mg | 44 | $8,085 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,426 | $181 |
| New patient visit (60+ min) | 27 | $4,755 | $176 |
| 3d radiographic procedure with computerized image postprocessing | 68 | $4,721 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $3,637 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,970 | $66 |
| Influenza vaccine split virus, preservative free | 53 | $2,848 | $54 |
| Transitional care management services for problem of at least moderate complexity | 16 | $2,522 | $158 |
| External ekg recording for more than 48 hours up to 21 days | 74 | $2,041 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 74 | $1,801 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 60 | $1,714 | $21 |
| Blood test, clotting time | 111 | $1,357 | $4 |
| Ultrasound of heart, follow-up | 12 | $1,319 | $94 |
| Administration of influenza virus vaccine | 54 | $1,090 | $20 |
| 3d radiographic procedure | 35 | $799 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $672 | $26 |
| Ultrasound of heart, follow-up | 12 | $346 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 11 | $255 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $104 | $9 |
2018: 26 services
| Long return visit (40+ min) | 235 | $62,108 | $123 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 306 | $61,837 | $198 |
| Return visit (30+ min) | 214 | $33,473 | $87 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $20,059 | $501 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 83 | $18,864 | $225 |
| Critical care, first 30-74 minutes | 17 | $9,713 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 492 | $7,748 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $7,712 | $92 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 40 | $7,635 | $95 |
| Injection, regadenoson, 0.1 mg | 34 | $6,015 | None |
| New patient visit (60+ min) | 28 | $5,149 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $4,351 | $66 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $3,105 | $78 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 48 | $2,933 | $61 |
| Transitional care management services for problem of high complexity | 11 | $2,410 | $219 |
| 3d radiographic procedure with computerized image postprocessing | 34 | $2,314 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 80 | $2,110 | $17 |
| Blood test, clotting time | 122 | $1,896 | $5 |
| Ultrasound of heart, follow-up | 14 | $1,830 | $108 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,423 | $89 |
| External ekg recording for more than 48 hours up to 21 days | 46 | $1,202 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 46 | $1,058 | $23 |
| Influenza vaccine split virus, preservative free | 23 | $1,007 | $44 |
| Administration of influenza virus vaccine | 24 | $607 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $509 | $27 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $501 | $28 |
2017: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 309 | $67,901 | $218 |
| Long return visit (40+ min) | 205 | $50,221 | $118 |
| Return visit (30+ min) | 223 | $35,991 | $87 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 115 | $30,616 | $266 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 28 | $13,567 | $485 |
| Critical care, first 30-74 minutes | 16 | $11,908 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $8,439 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 397 | $5,803 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 29 | $5,534 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $4,131 | $83 |
| Injection, regadenoson, 0.1 mg | 26 | $4,120 | None |
| New patient visit (60+ min) | 21 | $3,359 | $160 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 31 | $2,806 | $88 |
| Blood test, clotting time | 161 | $2,714 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 94 | $2,577 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 33 | $2,123 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $1,980 | $83 |
| Influenza vaccine split virus, preservative free | 19 | $838 | $44 |
| External ekg recording for more than 48 hours up to 21 days | 30 | $806 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $714 | $24 |
| Administration of influenza virus vaccine | 18 | $560 | $31 |
2016: 23 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $64,761 | $217 |
| Long return visit (40+ min) | 189 | $48,395 | $121 |
| Return visit (30+ min) | 271 | $46,818 | $84 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 100 | $24,954 | $250 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $19,686 | $469 |
| Critical care, first 30-74 minutes | 24 | $11,734 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $9,074 | $89 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $8,267 | $94 |
| New patient visit (60+ min) | 42 | $6,880 | $164 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 382 | $5,640 | $14 |
| Injection, regadenoson, 0.1 mg | 38 | $4,776 | None |
| Blood test, clotting time | 198 | $4,148 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $3,129 | $63 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 108 | $2,732 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $2,670 | $79 |
| Transitional care management services for problem of high complexity | 11 | $2,298 | $209 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $1,713 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,120 | $86 |
| External ekg recording for more than 48 hours up to 21 days | 24 | $648 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $560 | $23 |
| Influenza vaccine split virus, preservative free | 15 | $552 | $37 |
| Administration of influenza virus vaccine | 15 | $449 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $143 | $12 |
2015: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 291 | $67,029 | $228 |
| Long return visit (40+ min) | 174 | $47,104 | $129 |
| Return visit (30+ min) | 230 | $41,620 | $89 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 117 | $31,452 | $264 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $21,429 | $487 |
| New patient visit (60+ min) | 70 | $12,874 | $184 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 43 | $11,383 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $7,767 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 456 | $7,241 | $16 |
| Critical care, first 30-74 minutes | 18 | $5,637 | $194 |
| Blood test, clotting time | 209 | $4,800 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 140 | $4,183 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 38 | $3,393 | $87 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 52 | $3,282 | $63 |
| Transitional care management services for problem of high complexity | 11 | $2,282 | $207 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,098 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $885 | $55 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 30 | $849 | None |
| Influenza vaccine split virus, preservative free | 16 | $569 | $36 |
| Administration of influenza virus vaccine | 16 | $482 | $30 |
2014: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $56,133 | $225 |
| Long return visit (40+ min) | 152 | $40,415 | $117 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 130 | $37,017 | $274 |
| Return visit (30+ min) | 207 | $36,178 | $86 |
| New patient visit (60+ min) | 75 | $12,689 | $169 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $12,354 | $458 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $7,296 | $87 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 27 | $6,917 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 436 | $6,346 | $14 |
| Critical care, first 30-74 minutes | 13 | $5,854 | $183 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 147 | $4,691 | $17 |
| Blood test, clotting time | 175 | $3,018 | $5 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,588 | $118 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 41 | $2,559 | $62 |
| Transitional care management services for problem of high complexity | 11 | $2,489 | $207 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,314 | $80 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 24 | $1,643 | None |
| Ultrasound of heart blood flow, valves and chambers | 14 | $756 | $54 |
| Influenza vaccine split virus, preservative free | 15 | $491 | $33 |
| Administration of influenza virus vaccine | 16 | $477 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $368 | $26 |
2013: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | $39,505 | $180 |
| Long return visit (40+ min) | 127 | $29,237 | $120 |
| Return visit (30+ min) | 160 | $25,417 | $87 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 112 | $25,189 | $221 |
| New patient visit (60+ min) | 51 | $8,729 | $171 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 351 | $5,198 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 61 | $4,507 | $52 |
| Critical care, first 30-74 minutes | 12 | $3,640 | $182 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 91 | $3,162 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $2,847 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,537 | $85 |
| Extended office or other outpatient service, first hour | 17 | $1,506 | $84 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,250 | $83 |
| Blood test, clotting time | 110 | $1,231 | $5 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $865 | $67 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $795 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $578 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $363 | $20 |
Medicaid work
$91 in 2021
Medicaid paid $91 for 40 billed services this clinician did in 2021, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $91 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 26 | $0 |
| 2021 | 40 | 2 | 14 | $91 |
| 2020 | 27 | 2 | 13 | $0 |
| 2019 | 73 | 2 | 18 | $903 |
| 2018 | 71 | 2 | 17 | $375 |
See the largest Medicaid services in earlier years
2020
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $0 |
| Return visit (30+ min) | 14 | $0 |
2019
| Return visit (30+ min) | 18 | $833 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 55 | $71 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 58 | $291 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $84 |
Drugs they prescribed that Part D paid
$904,837
Pharmacies billed $904,837 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 5,010) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
4,355 generic and 655 brand-name prescriptions · $904,837 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 365 | $527,999 | $1,447 |
| Jardiance | 142 | $146,063 | $1,029 |
| Entresto | 42 | $60,275 | $1,435 |
| Multaq | 28 | $48,323 | $1,726 |
| Metoprolol | 530 | $7,128 | $13 |
See all 43 drugs
| Eliquis | 365 | $527,999 | $1,447 |
| Jardiance | 142 | $146,063 | $1,029 |
| Entresto | 42 | $60,275 | $1,435 |
| Multaq | 28 | $48,323 | $1,726 |
| Metoprolol | 530 | $7,128 | $13 |
| Atorvastatin | 706 | $5,936 | $8 |
| Dabigatran Etexilate | 21 | $5,387 | $257 |
| Valsartan | 108 | $4,473 | $41 |
| Zetia | 11 | $4,246 | $386 |
| Telmisartan | 109 | $4,198 | $39 |
| Rosuvastatin | 235 | $3,461 | $15 |
| Ezetimibe | 83 | $3,328 | $40 |
| Potassium Chloride | 121 | $2,683 | $22 |
| Amiodarone | 38 | $2,195 | $58 |
| Isosorbide Mononitrate Er | 104 | $1,963 | $19 |
| Hydralazine | 90 | $1,920 | $21 |
| Amlodipine Besylate | 382 | $1,895 | $5 |
| Irbesartan | 60 | $1,772 | $30 |
| Bumetanide | 32 | $1,771 | $55 |
| Losartan | 185 | $1,345 | $7 |
| Omega-3 Acid Ethyl Esters | 13 | $1,302 | $100 |
| Carvedilol | 177 | $1,275 | $7 |
| Diltiazem 24hr Er (Cd) | 48 | $1,266 | $26 |
| Digoxin | 61 | $1,133 | $19 |
| Clopidogrel | 73 | $1,071 | $15 |
| Lisinopril | 134 | $875 | $7 |
| Furosemide | 158 | $863 | $5 |
| Chlorthalidone | 45 | $849 | $19 |
| Isosorbide Dinitrate | 20 | $801 | $40 |
| Olmesartan Medoxomil | 52 | $758 | $15 |
| Nitroglycerin | 75 | $687 | $9 |
| Cilostazol | 12 | $662 | $55 |
| Pravastatin | 54 | $652 | $12 |
| Sotalol Af | 14 | $549 | $39 |
| Sotalol | 25 | $545 | $22 |
| Pantoprazole | 30 | $524 | $17 |
| Metoprolol | 93 | $518 | $6 |
| Spironolactone | 86 | $488 | $6 |
| Hydrochlorothiazide | 81 | $434 | $5 |
| Losartan-Hydrochlorothiazide | 17 | $295 | $17 |
| Atenolol | 24 | $254 | $11 |
| Simvastatin | 26 | $168 | $6 |
| Warfarin | 20 | $102 | $5 |
Year by year
| 2024 | 5,010 | 379 | 0% (0) | 13% | $904,837 |
| 2023 | 4,838 | 359 | 0% (0) | None | $834,427 |
| 2022 | 4,871 | 382 | 0% (0) | 12% | $781,894 |
| 2021 | 4,671 | 384 | 0% (0) | None | $705,695 |
| 2020 | 4,731 | 373 | 0% (0) | None | $657,536 |
| 2019 | 4,375 | 377 | 0% (0) | 13% | $514,968 |
| 2018 | 3,970 | 351 | 0% (0) | 14% | $435,645 |
| 2017 | 3,487 | 324 | 0% (0) | 18% | $326,319 |
| 2016 | 3,816 | 336 | 0% (0) | 17% | $285,665 |
| 2015 | 3,051 | 284 | 0% (0) | 20% | $197,940 |
| 2014 | 2,239 | 246 | 0% (0) | None | $132,928 |
| 2013 | 1,481 | 183 | 0% (0) | 22% | $76,758 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Eliquis | 351 | $500,343 | $1,425 |
| Multaq | 46 | $75,025 | $1,631 |
| Jardiance | 41 | $49,419 | $1,205 |
| Entresto | 23 | $41,306 | $1,796 |
| Dabigatran Etexilate | 21 | $13,161 | $627 |
| Atorvastatin | 655 | $10,173 | $16 |
| Metoprolol | 484 | $9,746 | $20 |
| Rosuvastatin | 217 | $6,792 | $31 |
| Amlodipine Besylate | 416 | $5,881 | $14 |
| Valsartan | 110 | $5,226 | $48 |
| Ezetimibe | 75 | $4,368 | $58 |
| Isosorbide Mononitrate Er | 85 | $4,143 | $49 |
| Telmisartan | 64 | $4,140 | $65 |
| Losartan | 199 | $4,132 | $21 |
| Potassium Chloride | 96 | $3,314 | $35 |
| Irbesartan | 68 | $3,232 | $48 |
| Carvedilol | 201 | $3,033 | $15 |
| Diltiazem 24hr Er (Cd) | 41 | $3,008 | $73 |
| Isosorbide Dinitrate | 40 | $2,502 | $63 |
| Digoxin | 68 | $2,262 | $33 |
| Hydralazine | 104 | $2,243 | $22 |
| Sotalol Af | 23 | $2,160 | $94 |
| Ranolazine Er | 16 | $2,061 | $129 |
| Lisinopril | 156 | $1,790 | $11 |
| Pravastatin | 78 | $1,712 | $22 |
| Clopidogrel | 75 | $1,471 | $20 |
| Candesartan Cilexetil | 11 | $1,460 | $133 |
| Furosemide | 182 | $1,409 | $8 |
| Bumetanide | 23 | $1,286 | $56 |
| Olmesartan-Hydrochlorothiazide | 14 | $1,185 | $85 |
| Amiodarone | 35 | $1,014 | $29 |
| Metoprolol | 106 | $1,004 | $9 |
| Nitroglycerin | 69 | $984 | $14 |
| Chlorthalidone | 35 | $972 | $28 |
| Omega-3 Acid Ethyl Esters | 18 | $940 | $52 |
| Sotalol | 22 | $925 | $42 |
| Olmesartan Medoxomil | 46 | $888 | $19 |
| Simvastatin | 36 | $648 | $18 |
| Spironolactone | 60 | $612 | $10 |
| Hydrochlorothiazide | 72 | $566 | $8 |
| Cilostazol | 14 | $490 | $35 |
| Bisoprolol | 13 | $447 | $34 |
| Warfarin | 21 | $407 | $19 |
| Pantoprazole | 27 | $354 | $13 |
| Atenolol | 26 | $281 | $11 |
| Losartan-Hydrochlorothiazide | 18 | $231 | $13 |
2022: 46 drugs
| Eliquis | 359 | $484,491 | $1,350 |
| Multaq | 57 | $78,781 | $1,382 |
| Pradaxa | 21 | $33,363 | $1,589 |
| Entresto | 20 | $29,736 | $1,487 |
| Vascepa | 16 | $10,424 | $651 |
| Jardiance | 12 | $9,721 | $810 |
| Atorvastatin | 715 | $9,162 | $13 |
| Metoprolol | 439 | $8,153 | $19 |
| Rosuvastatin | 198 | $7,358 | $37 |
| Isosorbide Dinitrate | 57 | $4,763 | $84 |
| Valsartan | 103 | $4,676 | $45 |
| Losartan | 213 | $3,478 | $16 |
| Ezetimibe | 82 | $3,247 | $40 |
| Carvedilol | 232 | $3,245 | $14 |
| Telmisartan | 34 | $3,107 | $91 |
| Amlodipine Besylate | 410 | $3,093 | $8 |
| Potassium Chloride | 129 | $3,076 | $24 |
| Irbesartan | 79 | $2,346 | $30 |
| Isosorbide Mononitrate Er | 81 | $2,131 | $26 |
| Hydralazine | 106 | $2,030 | $19 |
| Digoxin | 70 | $2,016 | $29 |
| Amiodarone | 25 | $1,968 | $79 |
| Olmesartan-Hydrochlorothiazide | 12 | $1,832 | $153 |
| Pravastatin | 77 | $1,632 | $21 |
| Diltiazem 24hr Er (Cd) | 36 | $1,493 | $41 |
| Lisinopril | 157 | $1,463 | $9 |
| Bumetanide | 23 | $1,306 | $57 |
| Clopidogrel | 69 | $1,170 | $17 |
| Furosemide | 209 | $1,127 | $5 |
| Candesartan Cilexetil | 11 | $1,043 | $95 |
| Sotalol Af | 16 | $918 | $57 |
| Chlorthalidone | 26 | $896 | $34 |
| Metoprolol | 112 | $876 | $8 |
| Nitroglycerin | 64 | $808 | $13 |
| Olmesartan Medoxomil | 30 | $719 | $24 |
| Sotalol | 16 | $634 | $40 |
| Spironolactone | 54 | $529 | $10 |
| Simvastatin | 42 | $475 | $11 |
| Hydrochlorothiazide | 85 | $474 | $6 |
| Bisoprolol | 13 | $368 | $28 |
| Benazepril | 16 | $315 | $20 |
| Omeprazole | 14 | $303 | $22 |
| Atenolol | 27 | $236 | $9 |
| Pantoprazole | 15 | $215 | $14 |
| Lovastatin | 15 | $139 | $9 |
| Warfarin | 16 | $128 | $8 |
2021: 44 drugs
| Eliquis | 347 | $424,486 | $1,223 |
| Multaq | 37 | $56,328 | $1,522 |
| Entresto | 41 | $40,569 | $989 |
| Pradaxa | 20 | $30,328 | $1,516 |
| Atorvastatin | 713 | $10,162 | $14 |
| Metoprolol | 391 | $9,465 | $24 |
| Rosuvastatin | 176 | $8,655 | $49 |
| Vascepa | 13 | $7,692 | $592 |
| Ezetimibe | 88 | $6,559 | $75 |
| Isosorbide Dinitrate | 41 | $4,330 | $106 |
| Irbesartan | 93 | $4,279 | $46 |
| Telmisartan | 36 | $3,538 | $98 |
| Valsartan | 70 | $3,491 | $50 |
| Potassium Chloride | 127 | $3,372 | $27 |
| Carvedilol | 241 | $3,219 | $13 |
| Amlodipine Besylate | 414 | $2,939 | $7 |
| Losartan | 223 | $2,674 | $12 |
| Isosorbide Mononitrate Er | 87 | $2,565 | $29 |
| Amiodarone | 33 | $2,181 | $66 |
| Ranolazine Er | 13 | $2,135 | $164 |
| Hydralazine | 90 | $2,082 | $23 |
| Digoxin | 43 | $1,836 | $43 |
| Pravastatin | 94 | $1,766 | $19 |
| Lisinopril | 173 | $1,587 | $9 |
| Diltiazem 24hr Er (Cd) | 29 | $1,556 | $54 |
| Sotalol Af | 23 | $1,544 | $67 |
| Chlorthalidone | 39 | $1,349 | $35 |
| Bumetanide | 16 | $1,183 | $74 |
| Furosemide | 205 | $1,167 | $6 |
| Olmesartan Medoxomil | 18 | $1,039 | $58 |
| Metoprolol | 103 | $889 | $9 |
| Clopidogrel | 51 | $745 | $15 |
| Cilostazol | 12 | $742 | $62 |
| Nitroglycerin | 47 | $626 | $13 |
| Labetalol | 11 | $598 | $54 |
| Sotalol | 17 | $578 | $34 |
| Hydrochlorothiazide | 74 | $518 | $7 |
| Spironolactone | 54 | $516 | $10 |
| Bisoprolol | 17 | $379 | $22 |
| Simvastatin | 46 | $357 | $8 |
| Benazepril | 19 | $315 | $17 |
| Atenolol | 26 | $209 | $8 |
| Warfarin | 14 | $183 | $13 |
| Lovastatin | 13 | $76 | $6 |
2020: 44 drugs
| Eliquis | 359 | $374,286 | $1,043 |
| Multaq | 47 | $69,702 | $1,483 |
| Entresto | 32 | $25,878 | $809 |
| Pradaxa | 19 | $25,338 | $1,334 |
| Atorvastatin | 643 | $11,623 | $18 |
| Metoprolol | 400 | $10,047 | $25 |
| Rosuvastatin | 174 | $9,651 | $55 |
| Ezetimibe | 91 | $7,570 | $83 |
| Vascepa | 11 | $7,094 | $645 |
| Irbesartan | 101 | $4,867 | $48 |
| Telmisartan | 50 | $4,053 | $81 |
| Amiodarone | 59 | $3,994 | $68 |
| Losartan | 256 | $3,858 | $15 |
| Valsartan | 34 | $3,704 | $109 |
| Isosorbide Dinitrate | 45 | $3,507 | $78 |
| Potassium Chloride | 121 | $3,421 | $28 |
| Diltiazem 24hr Er (Cd) | 28 | $2,892 | $103 |
| Ranolazine Er | 16 | $2,612 | $163 |
| Amlodipine Besylate | 397 | $2,497 | $6 |
| Carvedilol | 226 | $2,456 | $11 |
| Digoxin | 50 | $2,352 | $47 |
| Pravastatin | 91 | $2,032 | $22 |
| Isosorbide Mononitrate Er | 76 | $1,891 | $25 |
| Hydralazine | 94 | $1,665 | $18 |
| Lisinopril | 167 | $1,602 | $10 |
| Chlorthalidone | 45 | $1,435 | $32 |
| Midodrine | 11 | $1,233 | $112 |
| Furosemide | 232 | $1,192 | $5 |
| Metoprolol | 105 | $1,057 | $10 |
| Clopidogrel | 70 | $1,030 | $15 |
| Hydrochlorothiazide | 76 | $649 | $9 |
| Nitroglycerin | 41 | $636 | $16 |
| Torsemide | 18 | $606 | $34 |
| Warfarin | 52 | $598 | $12 |
| Pantoprazole | 27 | $508 | $19 |
| Bumetanide | 11 | $495 | $45 |
| Verapamil Er | 12 | $453 | $38 |
| Simvastatin | 60 | $402 | $7 |
| Olmesartan Medoxomil | 14 | $378 | $27 |
| Spironolactone | 49 | $367 | $7 |
| Atenolol | 30 | $300 | $10 |
| Benazepril | 20 | $286 | $14 |
| Bisoprolol | 12 | $224 | $19 |
| Lovastatin | 13 | $117 | $9 |
2019: 41 drugs
| Eliquis | 269 | $257,100 | $956 |
| Multaq | 44 | $70,785 | $1,609 |
| Pradaxa | 17 | $18,993 | $1,117 |
| Atorvastatin | 606 | $12,749 | $21 |
| Metoprolol | 372 | $11,637 | $31 |
| Livalo | 13 | $10,811 | $832 |
| Entresto | 12 | $8,657 | $721 |
| Ezetimibe | 78 | $7,557 | $97 |
| Rosuvastatin | 129 | $7,044 | $55 |
| Irbesartan | 139 | $5,926 | $43 |
| Amlodipine Besylate | 409 | $3,999 | $10 |
| Telmisartan | 68 | $3,750 | $55 |
| Carvedilol | 238 | $3,553 | $15 |
| Potassium Chloride | 92 | $3,444 | $37 |
| Losartan | 213 | $2,748 | $13 |
| Amiodarone | 23 | $2,743 | $119 |
| Pravastatin | 88 | $2,616 | $30 |
| Isosorbide Dinitrate | 31 | $2,303 | $74 |
| Hydralazine | 93 | $2,030 | $22 |
| Valsartan | 31 | $1,900 | $61 |
| Isosorbide Mononitrate Er | 63 | $1,867 | $30 |
| Lisinopril | 191 | $1,573 | $8 |
| Olmesartan Medoxomil | 27 | $1,548 | $57 |
| Digoxin | 31 | $1,503 | $48 |
| Chlorthalidone | 45 | $1,352 | $30 |
| Eplerenone | 13 | $1,203 | $93 |
| Nitroglycerin | 67 | $1,144 | $17 |
| Furosemide | 169 | $1,126 | $7 |
| Clopidogrel | 83 | $1,094 | $13 |
| Diltiazem 24hr Er (Cd) | 34 | $1,068 | $31 |
| Warfarin | 52 | $997 | $19 |
| Metoprolol | 94 | $695 | $7 |
| Simvastatin | 61 | $627 | $10 |
| Hydrochlorothiazide | 86 | $611 | $7 |
| Bisoprolol | 12 | $472 | $39 |
| Atenolol | 30 | $412 | $14 |
| Spironolactone | 39 | $391 | $10 |
| Diltiazem | 12 | $293 | $24 |
| Benazepril | 20 | $253 | $13 |
| Pantoprazole | 19 | $220 | $12 |
| Lovastatin | 11 | $116 | $11 |
2018: 40 drugs
| Eliquis | 209 | $182,497 | $873 |
| Multaq | 53 | $64,545 | $1,218 |
| Pradaxa | 38 | $27,257 | $717 |
| Metoprolol | 318 | $11,270 | $35 |
| Atorvastatin | 490 | $10,865 | $22 |
| Valsartan | 134 | $8,460 | $63 |
| Ranexa | 11 | $8,079 | $734 |
| Ezetimibe | 47 | $6,973 | $148 |
| Livalo | 13 | $6,631 | $510 |
| Rosuvastatin | 89 | $4,911 | $55 |
| Potassium Chloride | 64 | $3,494 | $55 |
| Isosorbide Dinitrate | 38 | $3,070 | $81 |
| Amlodipine Besylate | 365 | $3,029 | $8 |
| Carvedilol | 230 | $2,810 | $12 |
| Diltiazem 24hr Er (Cd) | 22 | $2,687 | $122 |
| Irbesartan | 102 | $2,542 | $25 |
| Losartan | 218 | $2,525 | $12 |
| Pravastatin | 93 | $2,391 | $26 |
| Hydralazine | 99 | $2,049 | $21 |
| Amiodarone | 16 | $2,004 | $125 |
| Warfarin | 74 | $1,629 | $22 |
| Isosorbide Mononitrate Er | 60 | $1,497 | $25 |
| Lisinopril | 168 | $1,310 | $8 |
| Digoxin | 21 | $983 | $47 |
| Clopidogrel | 78 | $967 | $12 |
| Furosemide | 168 | $897 | $5 |
| Eplerenone | 12 | $829 | $69 |
| Nitroglycerin | 46 | $739 | $16 |
| Chlorthalidone | 17 | $633 | $37 |
| Metoprolol | 100 | $606 | $6 |
| Bisoprolol | 11 | $510 | $46 |
| Simvastatin | 58 | $487 | $8 |
| Torsemide | 12 | $453 | $38 |
| Hydrochlorothiazide | 88 | $442 | $5 |
| Benazepril | 26 | $433 | $17 |
| Atenolol | 37 | $387 | $10 |
| Valsartan-Hydrochlorothiazide | 14 | $325 | $23 |
| Spironolactone | 26 | $281 | $11 |
| Lovastatin | 14 | $278 | $20 |
| Pantoprazole | 27 | $268 | $10 |
2017: 37 drugs
| Eliquis | 171 | $107,066 | $626 |
| Multaq | 60 | $60,299 | $1,005 |
| Xarelto | 29 | $22,793 | $786 |
| Valsartan | 153 | $11,340 | $74 |
| Metoprolol | 271 | $9,811 | $36 |
| Atorvastatin | 425 | $8,849 | $21 |
| Zetia | 21 | $8,809 | $419 |
| Rosuvastatin | 56 | $5,436 | $97 |
| Isosorbide Dinitrate | 40 | $4,261 | $107 |
| Diltiazem 24hr Er | 18 | $3,270 | $182 |
| Potassium Chloride | 65 | $3,109 | $48 |
| Amlodipine Besylate | 334 | $2,574 | $8 |
| Benicar | 12 | $2,509 | $209 |
| Warfarin | 80 | $2,215 | $28 |
| Carvedilol | 217 | $2,134 | $10 |
| Pravastatin | 86 | $2,122 | $25 |
| Digoxin | 40 | $1,752 | $44 |
| Losartan | 165 | $1,748 | $11 |
| Hydralazine | 78 | $1,437 | $18 |
| Lisinopril | 139 | $1,014 | $7 |
| Digox | 17 | $1,006 | $59 |
| Isosorbide Mononitrate Er | 51 | $787 | $15 |
| Furosemide | 139 | $725 | $5 |
| Clopidogrel | 58 | $690 | $12 |
| Simvastatin | 124 | $662 | $5 |
| Cartia Xt | 15 | $541 | $36 |
| Metoprolol | 87 | $491 | $6 |
| Jantoven | 17 | $452 | $27 |
| Atenolol | 52 | $430 | $8 |
| Benazepril | 26 | $428 | $16 |
| Spironolactone | 41 | $399 | $10 |
| Valsartan-Hydrochlorothiazide | 15 | $279 | $19 |
| Hydrochlorothiazide | 60 | $271 | $5 |
| Nitroglycerin | 13 | $244 | $19 |
| Lovastatin | 12 | $237 | $20 |
| Pantoprazole | 19 | $196 | $10 |
| Diltiazem | 18 | $116 | $6 |
2016: 51 drugs
| Eliquis | 116 | $58,122 | $501 |
| Multaq | 61 | $54,336 | $891 |
| Xarelto | 36 | $20,797 | $578 |
| Valsartan | 100 | $14,906 | $149 |
| Crestor | 24 | $11,766 | $490 |
| Ranexa | 12 | $9,965 | $830 |
| Atorvastatin | 416 | $8,008 | $19 |
| Metoprolol | 229 | $7,717 | $34 |
| Zetia | 22 | $7,191 | $327 |
| Isosorbide Dinitrate | 65 | $5,486 | $84 |
| Bystolic | 18 | $4,417 | $245 |
| Amlodipine Besylate | 365 | $2,857 | $8 |
| Carvedilol | 304 | $2,812 | $9 |
| Potassium Chloride | 69 | $2,658 | $39 |
| Benicar Hct | 11 | $2,614 | $238 |
| Warfarin | 120 | $2,145 | $18 |
| Hydralazine | 100 | $1,871 | $19 |
| Digoxin | 48 | $1,798 | $37 |
| Pravastatin | 83 | $1,750 | $21 |
| Rosuvastatin | 16 | $1,725 | $108 |
| Losartan | 148 | $1,274 | $9 |
| Metoprolol | 159 | $1,153 | $7 |
| Nitrostat | 34 | $1,097 | $32 |
| Diltiazem 24hr Er | 22 | $1,051 | $48 |
| Lisinopril | 140 | $925 | $7 |
| Digox | 15 | $908 | $61 |
| Furosemide | 164 | $862 | $5 |
| Clopidogrel | 86 | $858 | $10 |
| Simvastatin | 100 | $842 | $8 |
| Isosorbide Mononitrate Er | 49 | $789 | $16 |
| Atenolol | 67 | $662 | $10 |
| Bumetanide | 17 | $596 | $35 |
| Verapamil Er | 11 | $572 | $52 |
| Cartia Xt | 24 | $514 | $21 |
| Chlorthalidone | 14 | $459 | $33 |
| Telmisartan | 11 | $443 | $40 |
| Benazepril | 40 | $438 | $11 |
| Diltiazem Er | 13 | $402 | $31 |
| Torsemide | 13 | $392 | $30 |
| Lovastatin | 20 | $379 | $19 |
| Bisoprolol | 13 | $300 | $23 |
| Amiodarone | 15 | $299 | $20 |
| Diltiazem | 31 | $289 | $9 |
| Hydrochlorothiazide | 58 | $287 | $5 |
| Pantoprazole | 28 | $284 | $10 |
| Sotalol | 15 | $261 | $17 |
| Spironolactone | 33 | $261 | $8 |
| Valsartan-Hydrochlorothiazide | 14 | $249 | $18 |
| Nitroglycerin | 11 | $196 | $18 |
| Omeprazole | 17 | $161 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $106 | $10 |
2015: 39 drugs
| Multaq | 55 | $39,331 | $715 |
| Eliquis | 51 | $20,039 | $393 |
| Xarelto | 40 | $18,438 | $461 |
| Valsartan | 72 | $15,617 | $217 |
| Crestor | 39 | $12,159 | $312 |
| Pradaxa | 15 | $9,516 | $634 |
| Zetia | 28 | $8,634 | $308 |
| Atorvastatin | 296 | $6,981 | $24 |
| Ranexa | 11 | $6,908 | $628 |
| Isosorbide Dinitrate | 74 | $5,890 | $80 |
| Metoprolol | 177 | $5,874 | $33 |
| Diovan | 17 | $4,313 | $254 |
| Bystolic | 14 | $4,178 | $298 |
| Pravastatin | 66 | $2,229 | $34 |
| Carvedilol | 269 | $2,182 | $8 |
| Amlodipine Besylate | 293 | $2,111 | $7 |
| Pindolol | 18 | $1,839 | $102 |
| Clopidogrel | 65 | $1,232 | $19 |
| Warfarin | 84 | $1,226 | $15 |
| Potassium Chloride | 47 | $1,217 | $26 |
| Hydralazine | 71 | $1,167 | $16 |
| Losartan | 136 | $1,015 | $7 |
| Atenolol | 113 | $911 | $8 |
| Furosemide | 127 | $772 | $6 |
| Lisinopril | 149 | $767 | $5 |
| Simvastatin | 89 | $740 | $8 |
| Digoxin | 16 | $728 | $46 |
| Diltiazem Er | 18 | $640 | $36 |
| Digox | 18 | $635 | $35 |
| Bumetanide | 15 | $601 | $40 |
| Hydrochlorothiazide | 60 | $593 | $10 |
| Diltiazem 24hr Er | 21 | $591 | $28 |
| Metoprolol | 100 | $481 | $5 |
| Isosorbide Mononitrate Er | 27 | $432 | $16 |
| Nitrostat | 19 | $361 | $19 |
| Benazepril | 43 | $350 | $8 |
| Spironolactone | 40 | $283 | $7 |
| Pantoprazole | 28 | $224 | $8 |
| Diltiazem | 17 | $126 | $7 |
2014: 34 drugs
| Multaq | 39 | $23,325 | $598 |
| Diovan | 56 | $22,624 | $404 |
| Xarelto | 31 | $12,020 | $388 |
| Ranexa | 18 | $6,913 | $384 |
| Crestor | 19 | $6,697 | $352 |
| Atorvastatin | 219 | $5,732 | $26 |
| Valsartan | 13 | $5,027 | $387 |
| Metoprolol | 88 | $3,720 | $42 |
| Zetia | 14 | $3,653 | $261 |
| Pravastatin | 77 | $2,380 | $31 |
| Carvedilol | 195 | $2,340 | $12 |
| Isosorbide Dinitrate | 36 | $2,198 | $61 |
| Amlodipine Besylate | 183 | $1,728 | $9 |
| Diltiazem 24hr Er | 30 | $1,704 | $57 |
| Pindolol | 17 | $1,658 | $98 |
| Potassium Chloride | 33 | $1,522 | $46 |
| Clopidogrel | 46 | $1,270 | $28 |
| Digox | 17 | $1,237 | $73 |
| Warfarin | 68 | $1,033 | $15 |
| Losartan | 87 | $1,003 | $12 |
| Hydralazine | 52 | $890 | $17 |
| Simvastatin | 104 | $873 | $8 |
| Atenolol | 108 | $773 | $7 |
| Lisinopril | 107 | $656 | $6 |
| Nitrostat | 30 | $598 | $20 |
| Hydrochlorothiazide | 44 | $584 | $13 |
| Digoxin | 16 | $536 | $33 |
| Metoprolol | 111 | $509 | $5 |
| Furosemide | 75 | $365 | $5 |
| Spironolactone | 41 | $344 | $8 |
| Isosorbide Mononitrate Er | 24 | $324 | $13 |
| Diltiazem | 29 | $215 | $7 |
| Benazepril | 17 | $189 | $11 |
| Verapamil Er | 11 | $182 | $17 |
2013: 27 drugs
| Diovan | 37 | $16,176 | $437 |
| Multaq | 19 | $6,360 | $335 |
| Clopidogrel | 50 | $5,642 | $113 |
| Atorvastatin | 89 | $4,451 | $50 |
| Crestor | 14 | $4,332 | $309 |
| Xarelto | 11 | $3,486 | $317 |
| Metoprolol | 61 | $2,913 | $48 |
| Zetia | 13 | $2,163 | $166 |
| Amlodipine Besylate | 145 | $1,775 | $12 |
| Carvedilol | 122 | $1,569 | $13 |
| Isosorbide Dinitrate | 16 | $1,552 | $97 |
| Pravastatin | 47 | $1,326 | $28 |
| Klor-Con 10 | 14 | $1,269 | $91 |
| Losartan | 56 | $1,206 | $22 |
| Potassium Chloride | 23 | $1,048 | $46 |
| Simvastatin | 57 | $793 | $14 |
| Atenolol | 81 | $677 | $8 |
| Lisinopril | 79 | $638 | $8 |
| Furosemide | 72 | $582 | $8 |
| Hydrochlorothiazide | 33 | $523 | $16 |
| Warfarin | 44 | $513 | $12 |
| Metoprolol | 74 | $434 | $6 |
| Hydralazine | 21 | $433 | $21 |
| Spironolactone | 32 | $335 | $10 |
| Digox | 21 | $276 | $13 |
| Nitrostat | 14 | $218 | $16 |
| Digoxin | 11 | $108 | $10 |
Money from drug and device companies
$78 in 2025
A payment is not proof that care is biased.
See all 2 published payments
| Heartflow | Meals · 2025-12-03 | Ffrct | $30 |
| Cleerly | Meals · 2025-12-02 | Cleerly Ischemia | $48 |
Professional record
- NPI
- 1770534182
- Licence
- CA A88245California A88245: Current · expires 2028-07-31
- Trained
- Johns Hopkins University School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-05-12
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.